Harbor MedTech
Irvine
About Harbor MedTech
Harbor MedTech develops and commercializes tissue regeneration products for chronic wounds, hernia and joint repair, and more. It offers NeuvoCell, a wound therapy for chronic wounds, such as diabetic, venous, and pressure ulcers; products for hernia and joint repair, orthopedic soft tissue repair, breast reconstruction, and urogynecological repair; and Architect, a collagen matrix for treatment of partial and full-thickness skin wounds. Harbor MedTech, Inc. has a strategic partnership with Edwards Lifesciences. The company was founded in 2010 by Jim Jungwirth and Keith Myers and is based in Irvine, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2017)
- Website: harbormedtech.com
- Phone: 9496791086
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/harbor-medtech-99399 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.